Top Banner
Page 1 CURRENT TREND IN MEDICAL TREATMENT OF DRY EYE SYNDROME Prof. DR.Dr. Rukiah Syawal, Sp.M (K) Bagian Ilmu Kesehatan Mata Fakultas Kedokteran Universitas Hasanuddin Makassar
43

Current Treatment Des

Jan 30, 2016

Download

Documents

Faiz Nazri

des
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Current Treatment Des

Page 1

CURRENT TREND IN MEDICAL TREATMENT OF DRY EYESYNDROME

Prof. DR.Dr. Rukiah Syawal, Sp.M (K)Bagian Ilmu Kesehatan MataFakultas KedokteranUniversitas HasanuddinMakassar

Page 2: Current Treatment Des

Page 2

Page 3: Current Treatment Des

Page 3

WHAT IS DRY EYE ?

• N.E.I. (1993)

Dry Eye : Disorder of the tear film due to tear deficiency or excessive

evaporation which cause damage to the interpalpebral ocular surface and is

associated with symptoms of discomfort.

Page 4: Current Treatment Des

Page 4

• Foulks (2003)

Dry eye : A disturbance of the normal homeostatic interaction of the tear film and the ocular

surface.

Page 5: Current Treatment Des

Page 5

• Pflugfelder (2004)Dry eye : A disorder where by dysfunction

of the lacrimal function unit causes an unstable tear film which in turn promotion ocular surface inflammation,

epithelial disease and symptom of discomfort.

Page 6: Current Treatment Des

Page 6

• Dry Eye Workshop (DEWS) : 2007Dry eye : is a multifactorial disease of the tears

and ocular surface that results in symptoms of iscomfort, visual

disturbance and tear film instability with potential damage to the ocular surface. It is accompanied by increased osmolarity of the tear film and inflammation of the ocular surface

Page 7: Current Treatment Des

Page 7

Page 8: Current Treatment Des

Page 8

Normal tear film structure and components

Page 9: Current Treatment Des

Page 9

• Lacrimal Function Unit (LFU)→ an integrated system of :

♦ Lacrimal gland

♦ Ocular surface (cornea, conjunctiva)

♦ Palpebra and mebomian gland

♦ Sensory and motoric nerves

(nerv V1, nerv VII)

Page 10: Current Treatment Des

Page 10

Page 11: Current Treatment Des

Page 11

• Neural pathways linking components of the lacrimal functional unit

Page 12: Current Treatment Des

Page 12

Page 13: Current Treatment Des

Page 13

Disfunction of the lacrimal functional unit

Page 14: Current Treatment Des

Page 14

CLASSIFICATION OF DRY EYE

Page 15: Current Treatment Des

Page 15

MECHANISM OF DRY EYE

Page 16: Current Treatment Des

Page 16

RISK FACTORS

• Murube :

▪ Aging

▪ Hormonal

▪ Immunologi : autoimmun reaction

▪ Pharmacologic : topical, systemic

▪ Hyponutrition : vit.A deficiency, alcoholism

▪ Infection : HSK, trachoma

▪ Trauma : surgery

▪ Neurogenic : contact lens, post LASIK

▪ Defective gland

▪ Inability to utilize tears

Page 17: Current Treatment Des

Page 17

• DEWS : ● Aging

● Low androgen

● Drugs : systemic, topical

● Inflammatory lacrimal damage

● Refractive surgery

● Contact lens wear

● Environment

● Xerophthalmia

● Ocular allergy

Page 18: Current Treatment Des

Page 18

Page 19: Current Treatment Des

Page 19

SYMPTOM OF DRY EYE

Page 20: Current Treatment Des

Page 20

SIGN OF DRY EYE

1. Conjunctival hyperemia2. Conjunctival pleating3. Decrease of corneal sensation4. Debris in the tear film5. Irregular corneal surface6. Epithelial keratopathy7. Filamentary keratopathy8. Visual loss

1. Conjunctival hyperemia2. Conjunctival pleating3. Decrease of corneal sensation4. Debris in the tear film5. Irregular corneal surface6. Epithelial keratopathy7. Filamentary keratopathy8. Visual loss

Page 21: Current Treatment Des

Page 21

CLINICAL STAGE (MURUBE)

I. (Mild)

→ itching, photophobia, foreign body sensation

NO SIGN OF TISSUE ALTERATION

II. (Moderate)

→ punctate erosion, epithelial ulcer, hyperemia of the exposure conjunctiva, decrease of corneal sensation.

III. (Severe)

~ severe decrease of corneal sensation

~ corneal leucoma, neovascularisation

~ retraction of the conjunctiva

~ loss of vision

Page 22: Current Treatment Des

Page 22

TREATMENT OF DRY EYE

Page 23: Current Treatment Des

Page 23

Recommended Treatment Dry Eye

Page 24: Current Treatment Des

Page 24

MEDICAL TREATMENT

1. Lubricate ocular surface→ ARTIFICIAL TEAR

2. Supress inflammation3. Minimize exposure4. Reduced tear evaporation5. Stimulate lacrimal tears6. Punctal occlusion

Page 25: Current Treatment Des

Page 25

ARTIFICIAL TEARS THE MAINSTAY OF TREATMENT DRY EYE SYNDROME

Page 26: Current Treatment Des

Page 26

ARTIFICIAL TEARS

Page 27: Current Treatment Des

Page 27

• ARTIFICIAL TEARS~ CELLULOSE DERIVATES

~ POLYVINYL DERIVATES

~ CLHONDROITIN SULFATE

~ SODIUM HYALURONATE

~ GLYCEROL

~ LIPID EMULSION (mineral oil)

CATIONORM

Page 28: Current Treatment Des

Page 28

• METHYL CELLULOSE

Advantages :

Disadventages : Viscosity

- Synthetic colloid, stable pH - High degree of uniformity - Less 1 % : refractive index = tear film - Emollient action

- Blurred vision - Agglutination of cilia - Retardant effect of corneal wound healing

Page 29: Current Treatment Des

Page 29

• POLYVINYL ALCOHOL

♦ Less viscous♦ Emollient properties♦ More adhesive to cornea♦ No adverse effect on regeneration corneal epithel♦ Resembling the mucin

Page 30: Current Treatment Des

Page 30

• SODIUM HYALURONATE 0,1%

- Glycosaminoglycan, found in synovial fluid, vitreous humor- Holding large quantities of water- Lubricant~ Chondroitin sulfate (Limberg, Nelson)- Very effective (Sand, Pollack)- Long residence time- Improvement of blurred vision and foreign body sensation

Page 31: Current Treatment Des

Page 31

CATIONORM

CATIONORM

Page 32: Current Treatment Des

Page 32

TERAPI TERAPI DRY EYEDRY EYE

Artificial tearsLubricants

DemulcentsLipid emulsions

Memperbaiki lapisan aquous

• Memperbaiki lapisan lipid

• Menghambat penguapan aquous

I. LIPID EMULSI

Page 33: Current Treatment Des

Page 33

II. CATIONIC→ CETALKONIUM CHLORIDE (CKC) 0,002%

Sel epitel di permukaan kornea & konjungtiva bermuatan negatif (anionik) Lebih mudah berikatan dengan larutan yang bermuatan listrik positif.

ELECTROSTATIC ATTRACTION

Page 34: Current Treatment Des

Page 34

• Electrostatic attractionElectrostatic attraction Comparison of neutral,

anionic, & cationic

eye drops

Page 35: Current Treatment Des

Page 35

• Emulsi kationik mempermudah penyebaran di seluruh permukaan mata

• Emulsi kationik memperpanjang waktu residensi di permukaan mata

• Efek terapi emulsi kationik lebih lama

Cationorm sebagai Emulsi Lipid Kationik

Page 36: Current Treatment Des

Page 36

III. NANODROPLET♦ Ukuran partikel minyak

yang nano, membuat

ukuran tetesan menjadi

lebih kecil dan lebih encer.

♦ Ukuran partikel yang sangat

kecil meningkatkan kenyamanan

pasien.

Page 37: Current Treatment Des

Page 37

Emulsi lipid Kationik Nanodroplet

Meningkatkan bioavailabilitas Meningkatkan waktu residensi

Rasa nyaman pada permukaan mata lebih lama

Frekuensi penggunaan lebih jarang; pasien lebih disiplin

Cationorm sebagai Emulsi Lipid Kationik Nanodroplet

Page 38: Current Treatment Des

Page 38

INDIKASI CATIONORM● Dry eye syndrome

♦ Dry eye tipe evaporasi

♦ Meibomian gland dysfunction (MGD)

♦ Dry eye akibat faktor lingkungan, penggunaan lensa kontak

♦ Dry eye pasca operasi (bedah refraktif,katarak)

● Cationorm dapat digunakan bersama dengan vitadrop atau air mata artifisial lainnya apabila dibutuhkan.

● Perhatikan jarak waktu antar penetesan

Page 39: Current Treatment Des

Page 39

• ARTIFICIAL TEAR

- Tonicity

- Retention time

- Adherence to ocular surface

CATIONORM HAVE A BETTER RESPONSE

Page 40: Current Treatment Des

Page 40

Page 41: Current Treatment Des

Page 41

Page 42: Current Treatment Des

Page 42

First Page

"Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum."

Page 43: Current Treatment Des

Page 43

Second Page

"Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum."